Ocular Inflammation in Cataract Patients and Response to Treatment With Xiidra

Withdrawn before enrolling · Phase 4

Conditions studied: Dry Eye

In brief

To determine if the use of Xiidra® reduces ocular surface inflammation in preoperative and postoperative cataract patients.

Key facts

Study ID

NCT04120987

Run by

Bucci Laser Vision Institute

People needed

0

Starts

2021-05-31

Expected to finish

2022-06-25

Last updated by the study team

2023-07-27

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Positive for MMP-9 bilaterally as assessed by the Inflammadry assay

You may not qualify if…

• Negative Inflammadry assay in either eye
• Active diabetic retinopathy, uncontrolled glaucoma, uncontrolled uveitic inflammation
• Ocular surface diseases that might confound the interpretation of the InflammaDry assay

Where it is running

• Bucci Laser Vision — Wilkes-Barre, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.